Home ETF List About

Portfolio Holdings Detail for ISIN IE000D3BWBR2
Stock Name / FundiShares S&P 500 Swap UCITS ETF USD (Dist)
IssuerBlackrock
Entity holding fund iShares VI Public Limited Company
Entity Type
Entity LEI 549300VML6THE3JJOS76
ETF TickerI50D(USD) Euronext Amsterdam

Holdings detail for REGN

Stock NameRegeneron Pharmaceuticals Inc
TickerREGN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS75886F1075
LEI549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria
(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL
Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors
Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth
The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN
In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC
Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.
Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.
D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares S&P 500 Swap UCITS ETF USD (Dist) REGN holdings

DateNumber of REGN Shares HeldBase Market Value of REGN SharesLocal Market Value of REGN SharesChange in REGN Shares HeldChange in REGN Base ValueCurrent Price per REGN Share HeldPrevious Price per REGN Share Held
2025-09-26 (Friday)-14,199USD -8,006,816USD -8,006,816
2025-09-26 (Friday)14,199USD 8,006,816USD 8,006,816
2025-09-25 (Thursday)-14,199REGN holding increased by 28398USD -7,887,686REGN holding increased by 16080225USD -7,887,68628,398USD 16,080,225 USD 555.51 USD 0
2025-09-25 (Thursday)14,199REGN holding increased by 28398USD 7,887,686REGN holding increased by 16080225USD 7,887,68628,398USD 16,080,225 USD 555.51 USD 0
2025-09-24 (Wednesday)-14,199REGN holding decreased by -28398USD -8,192,539REGN holding decreased by -16385078USD -8,192,539-28,398USD -16,385,078 USD 149.46 USD 0
2025-09-24 (Wednesday)14,199REGN holding decreased by -28398USD 8,192,539REGN holding decreased by -16385078USD 8,192,539-28,398USD -16,385,078 USD 149.46 USD 0
2025-09-18 (Thursday)-21,658REGN holding increased by 43316USD -12,966,861REGN holding increased by 25647620USD -12,966,86143,316USD 25,647,620 USD 598.71 USD 0
2025-09-18 (Thursday)21,658REGN holding increased by 43316USD 12,966,861REGN holding increased by 25647620USD 12,966,86143,316USD 25,647,620 USD 598.71 USD 0
2025-09-17 (Wednesday)-21,658REGN holding increased by 43316USD -12,680,759REGN holding increased by 25135408USD -12,680,75943,316USD 25,135,408 USD 585.5 USD 0
2025-09-17 (Wednesday)21,658REGN holding increased by 43316USD 12,680,759REGN holding increased by 25135408USD 12,680,75943,316USD 25,135,408 USD 585.5 USD 0
2025-09-16 (Tuesday)-21,658REGN holding increased by 43316USD -12,454,649REGN holding increased by 24855803USD -12,454,64943,316USD 24,855,803 USD 575.06 USD 0
2025-09-16 (Tuesday)21,658REGN holding increased by 43316USD 12,454,649REGN holding increased by 24855803USD 12,454,64943,316USD 24,855,803 USD 575.06 USD 0
2025-09-15 (Monday)-21,658REGN holding decreased by -43316USD -12,401,154REGN holding decreased by -24802308USD -12,401,154-43,316USD -24,802,308 USD 146.09 USD 0
2025-09-15 (Monday)21,658REGN holding decreased by -43316USD 12,401,154REGN holding decreased by -24802308USD 12,401,154-43,316USD -24,802,308 USD 146.09 USD 0
2025-09-12 (Friday)-21,658USD -12,128,480USD -12,128,480
2025-09-12 (Friday)21,658USD 12,128,480USD 12,128,480
2025-09-11 (Thursday)-21,658USD -12,306,076USD -12,306,076
2025-09-11 (Thursday)21,658USD 12,306,076USD 12,306,076
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE000D3BWBR2

Show aggregate share trades of REGN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-25BUY28,398 555.510* 629.96
2025-09-24SELL-28,398 149.460* 632.51 Profit of 17,962,083 on sale
2025-09-18BUY43,316 598.710* 632.69
2025-09-17BUY43,316 585.500* 632.95
2025-09-16BUY43,316 575.060* 633.26
2025-09-15SELL-43,316 146.090* 635.91 Profit of 27,544,961 on sale
2025-09-10BUY43,316 555.830* 636.34
2025-09-09BUY43,316 556.530* 636.78
2025-09-08BUY43,316 558.440* 637.22
2025-09-05BUY43,316 573.380* 637.57
2025-09-04SELL-43,316 149.240* 640.30 Profit of 27,735,192 on sale
2025-08-29BUY18,254 580.700* 640.63
2025-08-28BUY18,254 579.610* 640.98
2025-08-27SELL-18,254 176.780* 643.62 Profit of 11,748,568 on sale
2025-08-07BUY88,868 559.800* 644.10
2025-08-06BUY88,868 555.130* 644.61
2025-08-05BUY88,868 569.900* 645.04
2025-08-04BUY88,868 571.540* 645.47
2025-08-01BUY88,868 558.870* 645.97
2025-07-31BUY88,868 545.460* 646.56
2025-07-30BUY88,868 554.580* 647.11
2025-07-29BUY88,868 558.145* 647.64
2025-07-28SELL-88,868 191.780* 650.37 Profit of 57,796,783 on sale
2025-07-24BUY88,868 564.640* 650.88
2025-07-23BUY88,868 572.390* 651.36
2025-07-22BUY88,868 560.930* 651.91
2025-07-21BUY88,868 545.530* 652.56
2025-07-18BUY88,868 542.520* 653.24
2025-07-17BUY88,868 550.000* 653.88
2025-07-16BUY88,868 547.930* 654.55
2025-07-15BUY88,868 547.960* 655.22
2025-07-14BUY88,868 570.590* 655.75
2025-07-11BUY88,868 567.740* 656.31
2025-07-10BUY88,868 559.760* 656.93
2025-07-09BUY88,868 552.580* 657.60
2025-07-08BUY88,868 547.750* 658.32
2025-07-07BUY88,868 538.110* 659.10
2025-07-04BUY88,868 547.360* 659.84
2025-07-03BUY88,868 547.360* 660.58
2025-07-02BUY88,868 547.740* 661.34
2025-06-30BUY88,868 525.000* 662.25
2025-06-27BUY88,868 521.000* 663.20
2025-06-26BUY88,868 521.000* 664.17
2025-06-25BUY88,868 520.290* 665.16
2025-06-24BUY88,868 522.270* 666.14
2025-06-23BUY88,868 511.920* 667.21
2025-06-20BUY88,868 509.720* 668.32
2025-06-19BUY88,868 513.580* 669.41
2025-06-18BUY88,868 513.580* 670.51
2025-06-17BUY88,868 508.860* 671.67
2025-06-16BUY88,868 522.680* 672.74
2025-06-13BUY88,868 529.240* 673.78
2025-06-12BUY88,868 521.840* 674.89
2025-06-11BUY88,868 518.600* 676.03
2025-06-10BUY88,868 523.530* 677.16
2025-06-09BUY88,868 517.600* 678.36
2025-06-06BUY88,868 493.220* 679.75
2025-06-05BUY88,868 483.070* 681.24
2025-06-04BUY88,868 484.930* 682.74
2025-06-03BUY88,868 487.860* 684.23
2025-06-02BUY88,868 490.810* 685.73
2025-05-30BUY88,868 490.280* 687.26
2025-05-29BUY88,868 605.390* 687.91
2025-05-28BUY88,868 591.850* 688.67
2025-05-27BUY88,868 603.260* 689.35
2025-05-26BUY88,868 588.340* 690.17
2025-05-23BUY88,868 588.340* 690.99
2025-05-22BUY88,868 596.850* 691.77
2025-05-21SELL-88,868 209.170* 695.75 Profit of 61,830,286 on sale
2025-04-29BUY72,394 568.910* 696.81
2025-04-28BUY139,452 610.860* 697.53
2025-04-25BUY139,452 602.640* 698.34
2025-04-24BUY144,856 599.760* 699.18
2025-04-23BUY150,260 587.850* 700.14
2025-04-22BUY150,260 585.490* 701.14
2025-04-21BUY150,260 561.490* 702.36
2025-04-18BUY150,260 563.160* 703.59
2025-04-17BUY150,260 563.160* 704.85
2025-04-16BUY150,260 549.280* 706.25
2025-04-15BUY150,260 557.910* 707.60
2025-04-14BUY150,260 571.060* 708.85
2025-04-11BUY150,260 554.180* 710.28
2025-04-10BUY150,260 546.390* 711.81
2025-04-09BUY150,260 576.720* 713.09
2025-04-08BUY150,260 556.810* 714.58
2025-04-07BUY150,260 572.780* 715.94
2025-04-04BUY150,260 573.450* 717.32
2025-04-02BUY150,260 625.600* 718.22
2025-04-01BUY150,260 617.000* 719.23
2025-03-31BUY150,260 634.230* 720.08
2025-03-28BUY150,260 637.360* 720.91
2025-03-27BUY150,260 635.830* 721.78
2025-03-26BUY67,058 640.140* 722.62
2025-03-10BUY83,202 744.830* 728.97
2025-03-07BUY150,260 707.510* 729.22
2025-03-06BUY67,058 698.440* 729.59
2025-02-14BUY42,100 673.600* 733.69
2025-02-13BUY42,100 674.270* 734.48
2025-02-12BUY42,100 663.860* 735.43
2025-02-11BUY42,100 665.460* 736.39
2025-02-10BUY42,100 690.360* 737.03
2025-02-07BUY42,100 710.000* 737.41
2025-02-06BUY42,100 722.070* 737.63
2025-02-05BUY42,100 716.720* 737.93
2025-02-04BUY42,100 697.050* 738.53
2025-02-03BUY42,100 666.850* 739.60
2025-01-31BUY42,100 672.980* 740.61
2025-01-30BUY42,100 683.080* 741.50
2025-01-29BUY42,100 687.270* 742.35
2025-01-28BUY42,100 686.330* 743.23
2025-01-27BUY42,100 684.710* 744.18
2025-01-24BUY42,100 675.790* 745.30
2025-01-23BUY42,100 694.640* 746.14
2025-01-22BUY42,100 680.030* 747.26
2025-01-21BUY42,100 687.800* 748.29
2025-01-20BUY42,100 681.580* 749.46
2025-01-17BUY42,100 681.580* 750.67
2025-01-15BUY42,100 703.430* 752.61
2025-01-14BUY42,100 690.870* 753.78
2025-01-13BUY42,100 716.900* 754.48
2025-01-09BUY42,100 733.590* 756.05
2025-01-08SELL-42,100 244.490* 766.49 Profit of 32,269,435 on sale
2025-01-02BUY42,100 715.190* 767.56
2024-12-31BUY42,100 712.330* 768.74
2024-12-30BUY42,100 702.590* 770.18
2024-12-27BUY42,100 712.400* 771.46
2024-12-26BUY42,100 716.680* 772.71
2024-12-20BUY42,100 701.850* 777.58
2024-12-19BUY42,100 708.250* 779.32
2024-12-18BUY42,100 714.620* 780.97
2024-12-17BUY42,100 740.010* 782.05
2024-12-11BUY42,100 773.000* 784.20
2024-12-10BUY42,100 778.500* 784.37
2024-12-09BUY42,100 788.000* 784.26
2024-12-06BUY42,100 778.000* 784.46
2024-12-05BUY42,100 767.900* 784.99
2024-12-04BUY42,100 754.260* 786.02
2024-12-03BUY42,100 749.570* 787.27
2024-12-02BUY42,100 762.340* 788.16
2024-11-29BUY42,100 750.220* 789.57
2024-11-28BUY42,100 754.870* 790.90
2024-11-25BUY42,100 749.510* 796.07
2024-11-22BUY42,100 738.000* 798.71
2024-11-21BUY42,100 744.500* 801.29
2024-11-20BUY42,100 743.350* 804.19
2024-11-19BUY42,100 744.600* 807.32
2024-11-12BUY42,100 821.000* 809.18
2024-11-11SELL-42,100 825.680* 808.15 Profit of 34,023,273 on sale
2024-11-08BUY42,100 828.420* 806.80
2024-11-05BUY42,100 829.430* 802.62
2024-11-01SELL-42,100 838.200* 796.44 Profit of 33,530,293 on sale
2024-10-29BUY42,100 927.330* 741.65
2024-10-28BUY42,100 928.610* 710.49
2024-10-23BUY42,100 941.390* 482.37
2024-10-18SELL-42,100 242.390* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19208,6591,635312,81266.7%
2025-09-18236,4853,679387,51961.0%
2025-09-17229,191716370,89561.8%
2025-09-16173,632584271,02064.1%
2025-09-15204,491251334,49661.1%
2025-09-12117,50433222,76052.7%
2025-09-11125,4783,137286,51643.8%
2025-09-10195,068481339,88557.4%
2025-09-09129,168994274,52047.1%
2025-09-08250,895396527,06247.6%
2025-09-05170,149290289,56658.8%
2025-09-04188,2272,103360,61952.2%
2025-09-03185,679344438,11142.4%
2025-09-02191,954138476,28840.3%
2025-08-29133,226685236,72656.3%
2025-08-28116,5602,177256,67545.4%
2025-08-27113,719465243,83646.6%
2025-08-26210,376450400,19952.6%
2025-08-25149,13068363,37741.0%
2025-08-22211,8223,244701,77030.2%
2025-08-21257,4923,416446,43957.7%
2025-08-20327,738572559,13358.6%
2025-08-19118,4722,191324,31136.5%
2025-08-18146,282388277,90952.6%
2025-08-15209,9233,375441,75247.5%
2025-08-14157,5693,623429,32736.7%
2025-08-13111,342233362,78630.7%
2025-08-12117,647171310,77537.9%
2025-08-11129,5132,676284,75745.5%
2025-08-08128,5591,038431,84129.8%
2025-08-07166,6481,560352,87747.2%
2025-08-06176,311624397,08944.4%
2025-08-05154,257115353,74443.6%
2025-08-04200,7581,913409,89749.0%
2025-08-01349,7753,745728,72048.0%
2025-07-31222,350476549,34440.5%
2025-07-30106,8391,689231,76146.1%
2025-07-29149,359276292,66751.0%
2025-07-28103,6871,380245,28742.3%
2025-07-25103,783556259,06940.1%
2025-07-24156,9742,397291,67753.8%
2025-07-23168,7341,708355,37247.5%
2025-07-22116,324617304,88038.2%
2025-07-2198,482900250,10739.4%
2025-07-18183,1741,051391,90946.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.